Multimodal Treatment Strategy for Locally Advanced Breast Cancer

REFERENCES

• International Union Against Cancer (UICC). TNM - Classification of malignant tumors. Hermanek P and Sobin, eds, 4th ed., 2nd revision, Springer-Verlag: Geneva, 1992.
   Google Scholar
• Schottenfeld D, Nash AG, Robbins GF, Beattie EJ. Ten-year results of the treatment of primary operable breast carcinoma. Cancer 1976; 38: 1001–1007.
   PubMed Web of Science ®Google Scholar
• Rubens PD, Armitage P, Winter PJ, Tong D, Hayward JL. Prognosis in inoperable stage III carcinoma of breast. Eur J Cancer 1977; 13: 805–811.
   PubMed Web of Science ®Google Scholar
• De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1978; 1: 53–59.
   PubMed Web of Science ®Google Scholar
• Bonadonna G. Conceptual and practical advances in the management of breast cancer. J Clin Oncol 1989; 7: 1380.
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN. Multidisciplinary management of advanced primary and metastatic breast cancer. Cancer 1994; 74: 416–23.
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN, Ames FC, Buzdar AU et al. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 1988; 62: 2507–2516.
   Google Scholar
• Nolê F, Aapro MS. Neoadjuvant chemotherapy in operable breast cancer. Oncol Pract 1996; 3: 3–7.
   Google Scholar
• Coukell AJ, Faulds D. Epirubicin - an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer. Drugs 1997; 53: 453–482.
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Brambilla C, Rossi A et al. Epirubicin in advanced breast cancer. The experience of the Milan Cancer Institute. In: Bonadonna G: Advances in anthracycline chemo-therapy: epirubicin. Milan: Masson, 1984: 63.
   Google Scholar
• Chabner BA, Myers CE. Clinical pharmacology of cancer chemotherapy In: De Vita VTj, Helmann S, Rosenberg SA. Cancer: principles and practices of oncology, 3rd Ed. Philadelphia: JB Lippincott, 1989: 376.
   Google Scholar
• Bissett D, Paul J, Wishant G. Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapy. R Coll Radiol 1995; 7 (1): 12–15.
   PubMedGoogle Scholar
• Miller AB, Hoogstraten B, Straquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214.
   PubMed Web of Science ®Google Scholar
• Perez CA, Brady LW. Principles and practice of radiation oncology. 2nd Ed., Philadelphia: JB Lippincott, 1992.
   Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339, 1-15: 71-85.
   Google Scholar
• Peacock LM, Leavitt DD, Gibbs FA Jr, Stewart JR. Electrons are therapy: clinical experience with chest wall irradiation. Int J Radiat Oncol Biol Phys 1984; 10: 2149–2153.
   PubMed Web of Science ®Google Scholar
• Perloff M, Lesnick GJ, Korzun A. Combination chemo-therapy with mastectomy or radiotherapy for stage III breast carcinoma: A Cancer and Leukemia Group B Study. J Clin Oncol 1988; 6: 261–269.
   PubMed Web of Science ®Google Scholar
• EORTC Breast Cancer Cooperative Group. Revision of standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 1980; 16: 1513–1515.
   Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
   Web of Science ®Google Scholar
• Breslow NE, Day NE. Statistical method in cancer research (vol 1). Lyon: IARC Publication N° 32, 1980.
   Google Scholar
• Hosmer DW, Lemeshow S. Applied logistic regression. New York: J Wiley & Sons, 1980.
   Google Scholar
• Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187–200.
   Google Scholar
• Dixon WJ. BMDP statistical software manual. Berkeley: University of California Press, 1992.
   Google Scholar
• Yabro JW. Future potential of adjuvant and neoadjuvant therapy. Sem Oncol 1991; 18: 613–619.
   PubMed Web of Science ®Google Scholar
• Perez CA, Graham ML, Taylor ME, Levy JF, Mortimer JE, Philpott GW. Management of locally advanced carcinoma of the breast (non inflammatory). Cancer 1994; 74 (suppl): 453-465.
   Google Scholar
• Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979; 39: 3861–3865.
   PubMed Web of Science ®Google Scholar
• Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978; 38: 2651–2656.
   PubMed Web of Science ®Google Scholar
• Morrow CS, Cowan KH. Antineoplastic drug resistance and breast cancer. Ann NY Acad Sci 1993; 698: 289–312.
   PubMed Web of Science ®Google Scholar
• MonteIla M, Biondi E, De Marco M et al. Sociodemographic factors associated with the diagnostic staging of breast cancer in Southern Italy. Cancer 1995; 76: 1585–1590.
   Google Scholar
• Mauriac L, Durand M, Avril A, Dilhuydy JM. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Ann Oncol 1991; 2: 347–354.
   PubMed Web of Science ®Google Scholar
• Ziegler LD, Connelly JH, Frye D, Smith TL, Hortobagyi GN. Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer. Cancer 1991; 68: 628–633.
   PubMed Web of Science ®Google Scholar
• Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR. Pathologic assessment of response to induction chemotherapy in breast cancer. Cancer Res 1986; 46: 2578–2581.
   PubMed Web of Science ®Google Scholar
• Mumtaz H, Davidson T, Spittle M et al. Breast surgery after neoadjuvant treatment. Is it necessary? Eur J Surg Oncol 1996; 22: 335–341.
   Google Scholar
• Scholl SM, Pierga JY, Asselain B et al. Breast tumor response to primary chemotherapy predicts local and distinct control as well as survival. Eur J Cancer 1995; 31A(12): 1969–75.
   Google Scholar
• Powles TJ, Hickish TF, Makris A et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995; 13: 547–552.
   PubMed Web of Science ®Google Scholar
• Scholl SM, Asselain B., Beuzeboc P et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: An update. Proc Am Soc Clin Oncol 1995; 14: 125 (Abstr 200).
   Google Scholar
• Cardin G, Rosso R, Campora E et al. Locally advanced non-metastatic breast cancer: analysis of prognostic factor in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer 1995; 31A: 1428-1433.
   Google Scholar
• Tubiana-Hulin M, Le Doussal V, Hacene K, Roussê J, Brunet M. Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgery. Cancer 1993; 72: 1261–1271.
   PubMed Web of Science ®Google Scholar
• Frierson HF, Fechner RE. Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy. Am J Clin Pathol 1994; 102: 154–157.
   PubMed Web of Science ®Google Scholar
• Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg 1995; 181: 202–208.
   PubMedGoogle Scholar
• McCready DR, Hortobagyi GN, Kau SW. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 1989; 121: 1291–1296.
   Google Scholar
• Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS. Progesterone receptors as a prognostic factor in stage II breast cancer. N Eng J Med 1983; 309: 1343–7.
   PubMed Web of Science ®Google Scholar
• Molino A, Turazza M, Bonetti A et al. Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. Oncology 1992; 49: 82–88.
   Google Scholar
• Montella M, Biondi E, De Marco MR et al. Breast cancer estrogen and progesterone receptors: a multivariate analysis of association with clinical and histologic characteristics in a series of 2933 consecutive cases. Int J Oncol 1996; 9: 977–982.
   Google Scholar
• Colozza M, Gori S, Mosconi AM et al. Induction chemotherapy with cisplatin, doxoubicin and cyclophos-phamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long term results. Am J Clin Oncol 1996; 19: 10–17.
   Google Scholar
• Jacquillart C, Weil M, Baillet F et al. Results of neoadju-vant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990; 66: 119–129.
   Google Scholar
• Piccart MJ, De Valeriola D, Paridaens R et al. Six-year results of a multimodality treatment strategy for locally advanced breast cancer. Cancer 1988; 62: 2501–2506.
   Google Scholar